Piper Sandler & Co’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Hold	0	–	–	–	17
2018 Q4	–	Sell	-12	Closed	-$9K	–	17
2018 Q3	$9K	Buy	+12	New	+$9K	0.01%	14